Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/15088
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChularojmontri L.
dc.contributor.authorWattanapitayakul S.K.
dc.contributor.authorHerunsalee A.
dc.contributor.authorCharuchongkolwongse S.
dc.contributor.authorNiumsakul S.
dc.contributor.authorSrichairat S.
dc.date.accessioned2021-04-05T04:32:34Z-
dc.date.available2021-04-05T04:32:34Z-
dc.date.issued2005
dc.identifier.issn9186158
dc.identifier.other2-s2.0-24944445527
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/15088-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-24944445527&doi=10.1248%2fbpb.28.1165&partnerID=40&md5=fbf1ff620ebc3611be524d8887a916bf
dc.description.abstractCardiac toxicity is a major adverse effect caused by doxorubicin (DOX) therapy. Many recent studies have shown that DOX toxicity involves generation of reactive oxygen species (ROS). Although protection or alleviation of DOX toxicity can be achieved by administration of antioxidant vitamins such as ascorbic acid and vitamin E, their cardioprotective effect remains controversial. Thus alternative naturally occurring antioxidants may potentially be candidates for antioxidant therapy. In this study, we investigated the antioxidative and cytoprotective effects of Phyllanthus urinaria (PU) against DOX toxicity using H9c2 cardiac myoblasts. The total antioxidant capacity of PU (1 mg/ml) was 5306.75±461.62 FRAP value (μM). DOX IC50 values were used to evaluate the cytoprotective effects of PU ethanolic extract (1 or 10 μg/ml) in comparison with those of ascorbic acid (VIT C, 100 μM) and N-acetylcysteine (NAC, 100 μM). PU treatments (1 or 10 μg/ml) dose dependently caused rightward DOX IC50 shifts of 2.8- and 8.5-fold, respectively while treatments with VIT C and NAC increased DOX IC50 by 3.3- and 4.2-fold, respectively. Additionally, lipid peroxidation and caspase-3 activity were parameters used to evaluate cytoprotective effect. All antioxidants completely inhibited cellular lipid peroxidation and caspase-3 activation induced by DOX (1 μM). Endogenous antioxidant defense such as total glutathione (tGSH), catalase and superoxide dismutase (SOD) activity was also modulated by the antioxidants. PU treatment alone dose dependently increased tGSH, and this effect was retained in the presence of DOX. Similar effect was observed in the assessment of catalase and SOD enzyme activity. The nuclear factor κB (NF κB) transcription factor assay demonstrated that all antioxidants significantly inhibited DOX-induced NF κB activation. Our results suggest that PU protection against DOX cardiotoxicity was mediated through multiple pathways and this plant may serve as an alternative source of antioxidants for prevention of DOX cardiotoxicity. © 2005 Pharmaceutical Society of Japan.
dc.subjectacetylcysteine
dc.subjectantioxidant
dc.subjectascorbic acid
dc.subjectcaspase 3
dc.subjectcatalase
dc.subjectdoxorubicin
dc.subjectglutathione
dc.subjectimmunoglobulin enhancer binding protein
dc.subjectPhyllanthus urinaria extract
dc.subjectplant extract
dc.subjectsuperoxide dismutase
dc.subjecttranscription factor
dc.subjectunclassified drug
dc.subjectanimal cell
dc.subjectantioxidant activity
dc.subjectarticle
dc.subjectcardiotoxicity
dc.subjectcell protection
dc.subjectcontrolled study
dc.subjectdose response
dc.subjectdrug effect
dc.subjectenzyme activation
dc.subjectenzyme activity
dc.subjectheart protection
dc.subjectIC 50
dc.subjectlipid peroxidation
dc.subjectnonhuman
dc.subjectPhyllanthus
dc.subjectphyllanthus urinaria
dc.subjectrat
dc.subjectAnimals
dc.subjectAntioxidants
dc.subjectCardiotonic Agents
dc.subjectCaspase 3
dc.subjectCaspases
dc.subjectCell Line
dc.subjectDoxorubicin
dc.subjectHeart
dc.subjectLipid Peroxidation
dc.subjectNF-kappa B
dc.subjectPhyllanthus
dc.subjectRats
dc.titleAntioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBiological and Pharmaceutical Bulletin. Vol 28, No.7 (2005), p.1165-1171
dc.identifier.doi10.1248/bpb.28.1165
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.